Malvern International Plc (AIM:MLVN)
17.00
-0.85 (-5.00%)
Aug 1, 2025, 4:35 PM GMT+1
Ligand Pharmaceuticals Market Cap
Malvern International has a market cap or net worth of 4.16 million as of August 1, 2025. Its market cap has decreased by -19.05% in one year.
Market Cap
4.16M
Enterprise Value
6.55M
Revenue
16.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
$17.00
Market Cap Chart
Since December 10, 2004, Malvern International's market cap has decreased from 6.56M to 4.16M, a decrease of -36.69%. That is a compound annual growth rate of -2.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 4.16M | -17.07% |
Dec 31, 2024 | 5.01M | -18.00% |
Dec 29, 2023 | 6.11M | 108.33% |
Dec 30, 2022 | 2.93M | -15.71% |
Dec 31, 2021 | 3.48M | 106.28% |
Dec 31, 2020 | 1.69M | -25.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Unilever | 109.82B |
British American Tobacco p.l.c. | 88.30B |
Diageo | 41.18B |
Reckitt Benckiser Group | 38.52B |
Tesco | 27.72B |
Imperial Brands | 23.94B |
Associated British Foods | 15.68B |
Coca-Cola HBC AG | 14.34B |